Furthermore, it is reported that the overexpression of either adiponectin receptor isoform in mouse liver is sufficient to improve ceramidase activity, total body glucose metabolism, and hepatic insulin sensitivity, while suppressing hepatic steatosis, in comparison to wild-type control animals [73]. This evidence concerns the gene INS and fatty liver disease.